As India’s Price Cuts Pinch, MNC Growth Plummets
This article was originally published in PharmAsia News
Executive Summary
Global drug makers are reeling from the harsh price cuts made in the Indian market since last year. The growth for foreign pharma firms in the country in July plummeted to 1.5%, creating the very real threat of loss of market share to a host of large and fast-growing smaller Indian players.